Healthcare Infrastructure, Operations & Supply ChainHekaBio, Alpha Tau Medical Get Japan Approval for Tumor TherapyBusiness WireFebruary 25, 2026February 26, 2026 by Business WireFebruary 25, 2026February 26, 2026015 Offering a New Option for Head and Neck Cancer Treatment HekaBio K.K., (Headquarters: Chuo-ku, Tokyo) announces that the innovative solid tumor treatment device ‘Alpha DaRT...
